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Differential expression of factor Xllla and
CD34 in cutaneous mesenchymal tumors
File histogenetic relalionship amongst various dendritic cells of
the dermis which may ex])ress markers including factor' Xll la
(FXlIIa) or' CD34 remains unclear. In this study we titilized
a sensitive indirect immunoperoxidase staining technique to
identify Cl)34 and I'XIIIa, as well the monocyte/macrophage
markers KP-I and MAC 387 expression in a variety of cutane-
ous dermal tumors of mesenchymal origin to see if dillerential
expression of CD34 vs FXIIIa exists, lumors studied included
dermatolibroma (DF) (N = 10), keloid (N = 9), atypical librox-
anthoma (AFX) (N = 3), and dermatofibrosarcoma protuberans
(DFSP) (N = 7). DF were all composed of FXIIIa+ spindle-
shaĵ ed and stellate tumor cells (mean score = 4.9 or > 75%
FXIIIa-f) as previously reported, but these cells rarely (< 10%)
expressed CD34. Six of 7 DFSP were found to be > 75%
CD344- and FXIIIa negative, while one DFSP was negative
for both CD34 and FXIIIa. In all DFSP, there were trapped
FXIIIa-f- cells which were distinct from the spindle-shaped
tumor cells. Al'X showed .sparse populations of FXIIIa-)- cells
in the stroma (mean score = 1.33 or 10—25% positive), which
were distinct from the atypical giant cells characteristic of these
tumors. Keloid similarly contained trapped FXIIIa + cells
(mean score = 0.44 or < 5% positive) that were distinct from the
spindle-shaped fibroblasts of the tumor mass. Dendritic and
spindle-sliaped cells within these tumors were consistently both
KP-1 and Mac-387 negative, while all lesions studied were char-
acterized by scattered round, histiocytic cells which were KP-l-l-
and/or Mac-387'f irrespective of tumor cell type. We suggest
I hat these tumors can be delineated by their relative degrees of
1 XII la and CD34 expression and that these neo]3lasms may be
a useful link with which to study the relationship between
CD34-i- cells and dermal dendrocytes.
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Recent work has demonstrated the presence of
(populations of dendritic cells in the dermis. One
subset of these cells are thought to be of bone mar-
row origin and are known as dermal dendrocytes
(I3D). 'l'hey express factor Xll la (FXIIIa) and
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have been shown to compose certain cutaneous tu-
mors such as dermatofibromas (1). FXIIIa+ DD
may be phagocytic and have been proposed to be
antigen presenting cells (APC) distinct from Lan-
gerhans cells and other APC of the skin (2,3). A
similar population of dendritic cells, which express
the antigen CD34, has also recently been identified
in human reticular dermis, often in coexistence with
FXIIIa4- DD (4). CD34 has been described as a
154
Factor Xlila vs CD34 in dermal tumors























4.43 ±0 .57** *
(n = 7)
* The values expressed are the mean ± SEM (based on tbe scale below)
for cells of dendritic/spindle-shaped morphology within the tumor
mass. In the keloids, atypical fibroxanthomas and dermatofibrosar-
coma protuberans lesions FXIIIa+ cells were trapped within the tumor
mass yet distinct from tumors cells. The semiquantitative average of
10-40X high power fields within the dermal tumor mass was scored as:
0 = none of tumor cells.
1 = <10% of fumor cells.
2 = 10-25% of tumor cells.
3 = 25-50% of tumor cells.
4 = 50-75% of tumor cells.
5 = >75% of tumor cells.
** = Significanf pairwise comparison vs keloid and dermatofibrosar-
coma protuberans (p<0.05).
*** = Significant pairwise comparison vs keloid and dermatofibroma
(p<0.05).
hematopoietic progetiitor antigen is expressed by
< 1% of bone marrow cells. It is unclear if CD34 +
dendritic cells may denote a similar stem cell popu-
lation in the skin. If so, these cells may serve as a
reservoir of mesenchymal precursor cells which
could differentiate upon appropriate stimulation
into FXIIIa-f DD (3,4).
The current study employs a sensitive immunope-
roxidase staining technique to identify populations
of both CD34+ and FXIIIa+ dendritic cells within
tumors of mesenchymal origin including, dermato-
fibromas (DF), atypical fibroxanthoma (AFX), der-
matofibrosarcoma protuberans (DFSP), and keloid.
We report significant differential expression of
FXIIIa and GD34 in these cutaneous tumors.
Material and methods
Patients
Subjects were identified by diagnosis from biopsy
records on file in the Departments of Pathology at
Henry Ford Hospital, and the University of Michi-
gan Medical Center. Included in this study were
serial paraOln sections from 10 DF, 9 keloids, 3
AFX, and 7 DFSP. Original hematoxylin and eosin
slides were reviewed to confirm the recorded diag-
noses.
Indirect immunoperoxidase
Indirect immunoperoxidase (IPX) staining was
performed on 4 fxm paralTin-imbedded sections
which were deparafllnized in xylene and dehydrated
in ethyl alcohol. Sections were incubated for 40 min
with trypsin 0.1% (Sigma, St. Louis, MO) in phos-
phate bulfered saline 0.05M (PBS), with CaCl,
0.1%. Endogenous peroxidase activity was in-
hibited with equal proportions of 100% methanol
and 3% hydrogen peroxide, prior (o blockage with
horse serum and exposure to primary antibodies for
1 h at room temperature. Antibodies used were
diluted in PBS with 0.5% bovine serum albumin
and included: anti-human FXIIIa (1:400) and
FXIHs (1:400) (Calbiochem, Lajolla, CA),
Mac-387 (1:50), KP-1 (1:50) (Dako, Carperteria,
CA), and CD34 (1:10) (HPCA-1, Becton Dickinson,
Mountainview, CA). Antibodies were visualized
using the avidin/biotin peroxidase technique (Vec-
tastain ABC Kit, Vector Labs Inc, Burlingame,
CA). The chromagen was 3-amino, 9-ethyl carba-
zole (AEC-Sigma, St. Louis, MO). All post-fixation
procedures were performed at room temperature.
An irrelevant, isotype-matched antibody was in-
cluded in each experiment as a control.
Dendritic and spindle-shaped dermal cells from
within these tumors with positive staining by the
IPX technique were evaluated semiquantitatively
by scoring the average number positive cells within
the dermal tumor mass in 10 high-power fields
(40X), employing the following scoring system: 0 =
no dendritic/spindle-shaped cell staining, 1 =
< 10% of dendritic/spindle-shaped cell staining,
2= 10—25% of dendritic/spindle-shaped cell stain-
ing, 3 = 25-50% of dendritic/spindle-shaped cell
staining, 4 = 50-75% of dendritic/spindle-shaped
cell staining, 5 = > 75% of dendritic/spindle-
shaped cell staining. Only those cells with visible
nuclei and discernable processes were included in
this analysis.
Statistical analysis
A non-parametric analysis of variance (Kruskal-
Wallis test) was first performed for the mean FXI-
IIa and CD34 expression within each disease group.
To study FXIIIa and CD34 staining among the DF,
keloid, AFX, and DFSP groups, pairwise compari-
sons were used with Bonferoni's correction for mul-
tiple comparisons.
Results
The results are summarized in Table 1. .\11 DF
(N = 10) studied expressed FXIIIa on the majority
of spindle-shaped and stellate tumor cells (Fig. la).
The average score (± SEM) of DF tumor cell ex-
pression of FXIIIa was 4.90 ± 0.10. CD34 staining
of these tumor cells was rare, and CD34-)- cells were




/•';•. /. Demonstration ol Factor X Ilia + dendritic cells in dermatofibroma by immunoperoxidasc staining (Fig. IA, X 10) and CD34 +
cells limited the vessels in the same lesion (Fig. IB, X 50).
Fig. 2. Demonstration of the universal expression of CD34 by spindle-shaped tumors cells in dermatofibrosarcoma protuberans by
immunoperoxidase staining (Fig. 2A, X 5, 2B, X 25) and the sparcc number of FXIIIa+ cells scatteted throughout the .same lesion
(Fig. 2C, X 5, 2D, X 25). Note how CD34 allows demonstration of the deeply invasive aspects of the tumor in the subcutaneous fat.
156
Factor Xllla vs CD34 in dermal tumors
dendrilic cells in the reticnlar dermis with similar
morphology as previously described (Fig. Ib) (4).
Many of the stromal cells in AFX (N — 3) were
dendritic and some expressed FXIIIa (mean score
= 1.3 ± 0.35). CD34 staining was rarely seen on any
of these dendritic cells. In none of the AFX were
> 2 5 % of lesional cells FXIIIa4- and these cells
composed a separate population of supporting cells,
readily distinguished from the atypical giant cells
and foam cells characteristic of AFX.
Four of 9 keloids also contained scattered FXI-
IIa+ dendritic cells in the tumor mass. These cells
were morphologically distinct from the spindle-
shaped fibroblasts in the keloid and appeared as if
trapped within the tumor mass. CD34 expression in
a keloid was limited to the vascular endothelium.
CD34 consistently stained all the large, atypical,
spindle-shaped tumor cells within 6/7 DFSP,
whereas one case was repeatedly CD34 negative.
The mean CD34 score for the 7 cases was
4.43 ± 0.57. CD34 delineated the deeper, more in-
vasive aspects ofthe tumors (Figs 2a,b). All DFSP
studied showed scattered FXIIIa-l- small dendritic
cells of typical DD morphology (Figs 2c,d). The
mean score for FXIIIa expression by the 7 DFSP
studied was 1.0, consistent with this scattering of
normal appearing DD trapped within the lesions.
Similar to prior reports, we found Mac-387 and
KP-1 did not identify DD in paraffin sections (2, 5).
In the tumors studied, Mac-387 and KP-1 stained
scattered dermal cells characterized by large histio-
cytic cells, pale nuclei, abundant cytoplasm and a
lack of distinct dendritic processes.
Statistically significant increases in FXIIIa-l-
cells were shown for the DF group as compared to
the keloids and DFSP (p < 0.05) CD34-I- cells were
significantly increased in the DFSP group as com-
pared to the DF and keloid groups (p < 0.05). Com-
parisons of AFX vs DFSP and AFX vs DF were not
statistically relevant due to the small numbers of
cases.
Discussion
Dendritic cells of the dermis have recently been the
focus of intensive work. Cerio et al. defined dermal
dendrocytes as a population of dendritic cells in the
upper dermis of normal skin which express FXIIIa
as well as HLA-DR (5). These cells also express
CD 14, CD45, and CD54, suggesting a mononuclear
cell origin for DD (2). In normal human skin,
FXIIIa + DD are located perivascularly and lim-
ited to the papillary and upper reticular dermis. A
morphologically similar, CD34-l-/FXIIIa negative
population of dendritic cells has been recently iden-
tified and is concentrated immediately below the
FXIIIa-l- DD in the deep reticular dermis (3,4).
CD34 is a monomeric 115-kd glycoprotein expres-
sed on hematopoietic progenitor cells in bone mar-
row as well as on endothelial cells in the skin and a
wide variety of vascular and spindle-shaped cell
tumors (4, 6-8).
FXIIIa and CD34 are both reported to be ex-
pressed by populations of spindle-shaped tumor
cells within Kaposi's sarcoma (KS) (4, 9, 10). CD34
and FXIIIa co-expression by various proportions of
spindle-shaped cells within KS lesions has led to
speculation of a histogenetic connection between
these two cell populations. KS cells were previously
felt to be a neoplastic proliferation of endothelial
cells alone, but have been recently suggested to be
related to DD as well (9).
Although the sample sizes studied were not large,
the current study demonstrates that dilTerential ex-
pression of CD34 and FXIIIa by dendritic cells
within benign and malignant mesenchymal dermal
tumors is more regularly seen than co-expression,
and may prove to be a useful method to delineate
these lesions histologically. Similar to recent re-
ports, we found the spindle-shaped cells in 6/7
DFSP to be CD34-f and FXIIIa negative (8,9).
Our finding in DF and keloid demonstrated that
there are distinct FXIIIa/CD34 profiles for eaeh of
these benign tumors as well. If supported by larger
studies, differential FXIIIa vs CD34 expression in
these tumors may become a useful immunohisto-
chemical adjunct in histologic delineation as in gen-
eral: DF are FXIIIa+ and CD34 negative, DFSP
are FXIIIa negative and CD34-I-, and keloids are
both FXIIIa and CD34 negative.
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